{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:22:58Z","timestamp":1783570978606,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nmcd-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.numecd.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,8,14]],"date-time":"2017-08-14T16:46:28Z","timestamp":1502729188000},"page":"850-857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"V.","family":"Trimarco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9195-5977","authenticated-orcid":false,"given":"A.","family":"Battistoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0635-4921","authenticated-orcid":false,"given":"G.","family":"Tocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Coluccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.","family":"Manzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0308-2836","authenticated-orcid":false,"given":"R.","family":"Izzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"37","key":"10.1016\/j.numecd.2017.08.003_bib1","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias","volume":"2016","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2017.08.003_bib2","first-page":"2","article-title":"Joint position statement on \u201cNutraceuticals for the treatment of hypercholesterolemia\u201d of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA)","volume":"27","author":"Pirro","year":"2017","journal-title":"NMCD"},{"key":"10.1016\/j.numecd.2017.08.003_bib3","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/mnfr.201600233","article-title":"Morus alba extract modulates blood pressure homeostasis through eNOS signaling","volume":"60","author":"Carrizzo","year":"2016","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.numecd.2017.08.003_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40292-015-0087-2","article-title":"Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial","volume":"22","author":"Trimarco","year":"2015","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.numecd.2017.08.003_bib5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2017.08.003_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacl.2013.11.003","article-title":"Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus","volume":"8","author":"Ruscica","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.numecd.2017.08.003_bib7","first-page":"26","article-title":"Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation","volume":"57","author":"Cicero","year":"2007","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.numecd.2017.08.003_bib8","doi-asserted-by":"crossref","first-page":"23587","DOI":"10.1038\/srep23587","article-title":"Effects of a nutraceutical combination on lipids, inflammation and endothelial integrity in patients with subclinical inflammation: a randomized clinical trial","volume":"6","author":"Pirro","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.numecd.2017.08.003_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-511X-11-123","article-title":"Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment","volume":"11","author":"Pisciotta","year":"2012","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2017.08.003_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.arteri.2016.03.002","article-title":"Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: a meta-analysis of randomised controlled trials","volume":"28","author":"Mill\u00e1n","year":"2016","journal-title":"Clin Investig Arterioscler"},{"key":"10.1016\/j.numecd.2017.08.003_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.phrs.2016.04.021","article-title":"The effects of a nutraceutical combination on plasma lipids and glucose: a systematic review and meta-analysis of randomized controlled trials","volume":"110","author":"Pirro","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.numecd.2017.08.003_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosissup.2016.10.003","article-title":"A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: review of the clinical evidence","volume":"24","author":"Barrios","year":"2017","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.numecd.2017.08.003_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2147\/IJWH.S115948","article-title":"Effects of a new combination of nutraceuticals on postmenopausal symptoms and metabolic profile: a crossover, randomized, double-blind trial","volume":"8","author":"Trimarco","year":"2016","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.numecd.2017.08.003_bib14","first-page":"656","article-title":"Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study","volume":"20","author":"Affuso","year":"2010","journal-title":"NMCD"},{"key":"10.1016\/j.numecd.2017.08.003_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8983232","article-title":"Evaluation of a standardized extract from Morus alba against alpha-glucosidase inhibitory effect and postprandial antihyperglycemic in patients with impaired glucose tolerance: a randomized double-blind clinical trial","author":"Hwang","year":"2016","journal-title":"Evid Based Compl Altern Med eCAM"},{"key":"10.1016\/j.numecd.2017.08.003_bib16","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1161\/01.CIR.101.15.1780","article-title":"Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance","volume":"101","author":"Balletshofer","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2017.08.003_bib17","doi-asserted-by":"crossref","first-page":"10J","DOI":"10.1016\/S0002-9149(03)00611-8","article-title":"Role of endothelial dysfunction in insulin resistance","volume":"92","author":"Hsueh","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2017.08.003_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40292-016-0171-2","article-title":"The age of nutraceuticals: exploring new therapeutic targets","volume":"23","author":"Volpe","year":"2016","journal-title":"High Blood Press Cardiovasc Prev"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475317301837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475317301837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T10:55:44Z","timestamp":1535453744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475317301837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0939475317301837"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2017.08.003","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single blind, multicentre, randomized, controlled trial testing the effects of a novel nutraceutical compound on plasma lipid and cardiovascular risk factors: Results of the interim analysis","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}